2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one has been researched along with Muscle Spasticity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwarz, M; Sontag, KH; Turski, L | 1 |
| Ikonomidou, C; Klockgether, T; Schwarz, M; Sontag, KH; Turski, L | 1 |
2 other study(ies) available for 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one and Muscle Spasticity
| Article | Year |
|---|---|
CGS 8216, Ro 15-1788 and methyl-beta-carboline-3-carboxylate, but not EMD 41717 antagonize the muscle relaxant effect of diazepam in genetically spastic rats.
Topics: Animals; Benzodiazepinones; Carbolines; Convulsants; Diazepam; Electromyography; Female; Flumazenil; Imidazoles; Kinetics; Male; Muscle Contraction; Muscle Relaxation; Muscle Spasticity; Pyrazoles; Rats; Rats, Mutant Strains | 1984 |
Effects of methyl beta-carboline-3-carboxylate, Ro 15-1788 and CGS 8216 on muscle tone in genetically spastic rats.
Topics: Animals; Benzodiazepinones; Carbolines; Dose-Response Relationship, Drug; Electromyography; Female; Flumazenil; Male; Muscle Spasticity; Muscle Tonus; Pyrazoles; Rats; Rats, Mutant Strains; Receptors, GABA-A | 1985 |